B
Beijing Yuanxin Technology
With online and offline channels, Yuanxin integrates hospital and out-of-hospital resources and delivers integrated medical insurance solutions
About Beijing Yuanxin Technology
Founded in 2015 by He Tao and Daoliang Han, Beijing Yuanxin Technology Group operates as a significant player in China's healthcare technology sector. He Tao, an industry veteran with extensive experience in internet healthcare, previously led the creation of Jianyi Online Pharmacy for China Resources Group before establishing Yuanxin. The company has successfully attracted substantial investment from prominent firms including Tencent, Sequoia Capital China, Qiming Venture Partners, and OrbiMed. Yuanxin has also pursued a public listing on the Hong Kong Stock Exchange, filing prospectuses in October 2021 and April 2022, though the listing has been postponed.
Yuanxin Technology's business model is centered on the patient's entire medical journey, integrating online and offline services to bridge gaps between medical care, pharmaceutical distribution, and health insurance. The firm's operations are structured around three core pillars: out-of-hospital comprehensive patient services, supply-side empowerment, and innovative healthcare services. The majority of its revenue is generated from out-of-hospital patient services, which accounted for 94.6% of total revenue in 2021. This primary segment includes a network of brick-and-mortar pharmacies and the 'Miaoshou Doctor' platform, which was one of the first licensed internet hospitals in China. As of late 2021, the company operated 264 'Yuanxin Pharmacy' branded locations across 30 provinces, complemented by the Miaoshou Doctor online platform, which had an average of 40.2 million monthly users.
The company's key service offerings create a closed-loop system of 'medical-pharmaceutical-insurance'. Through 'Miaoshou Doctor', patients can access services like follow-up consultations and prescription management. The supply-side empowerment services provide hospitals with digital tools and management solutions to improve operational efficiency. The innovative healthcare services division develops solutions for pharmaceutical companies and insurers, including the 'Yuanxin Huibao' insurance technology platform, which assists insurance companies with integrated medical services and data analytics. This platform was established in 2019 to focus on developing novel payment solutions and inclusive insurance products, aiming to make innovative drugs more accessible and affordable for patients.
Source: Dealroom company dataKnowledge graph
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES FOther financing | Aug 2021 | $210M | $2.3B | Sequoia · OrbiMed · Index Capital · UOB Venture | ↗ |
| SERIES EOther financing | Feb 2021 | $465M | $1.9B | CICC · Sequoia · Tencent · CITIC Securities | ↗ |
Growth signals
Latest recorded traffic for Beijing Yuanxin Technology is 23K monthly website visits, up 32757.1% over the last three months. Beijing Yuanxin Technology's team declined 15.4% over the past year.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Beijing Yuanxin Technology in its local ecosystem
The Beijing Yuanxin Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later11 investors entered at this stage
Sequoia
Tencent
Qiming Venture Partners- ICIndex Capital
CICC
CITIC Securities
OrbiMed
UOB Venture
SpringHill Management- EFEFund
Kunling Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Beijing Yuanxin Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Beijing Yuanxin Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.